Kardium

Vancouver, Canada - September 10, 2026 - Kardium Inc., a medical device solutions company behind the Globe System, announced the launch of the "Globe Durability Guarantee", which is designed to provide patients and physicians with additional confidence in

The company received FDA approval for its pulsed field ablation system last year and closed a $250 million funding round.

Kardium will receive up to $31.25 million from the Government of Canada to support a $125 million project expanding manufacturing capacity for its Globe Pulsed Field System in Vancouver, British Columbia. The federal funding is being provided through Cana

German chemical giant Evonik is also getting $68 million to expand its BC presence.

VANCOUVER, B.C. - August 27, 2026 - The Government of Canada today announced funding of up to $31.25 million through the Strategic Response Fund (SRF) toward Kardium's investment in a $125 million project to expand its manufacturing capabilities in Vancou

$31.25-million will allow medical-device developer to expand manufacturing capabilities in greater Vancouver area; German chemicals giant Evonik also gets Ottawa's help to expand presence in the province

Device is meant to treat atrial fibrillation, a serious medical condition which causes a fast and uneven heartbeat

Vancouver, BC - Aug 6, 2026 - Kardium Inc., a private medical device company that's advancing the way the world treats atrial fibrillation (AF), announced today that Health Canada has granted a Medical Device Licence for the Globe Pulsed Field System. Bui